譚永輝醫生 - 感染及傳染病科
感染及傳染病科專科醫生
重點資料
- 醫務委員會註冊已驗證
- 感染及傳染病科專科醫生香港大學內外全科醫學士 · 香港內科醫學院院士 · 2013 年醫科畢業
- 保險計劃資料整理中｜查看詳情
關於醫生
譚永輝醫生是香港註冊的感染及傳染病科專科醫生。
學歷
保險計劃
常見問題
譚永輝醫生好嗎？
譚永輝醫生是香港註冊的感染及傳染病科專科醫生。資歷及註冊資料來自香港醫務委員會。ok.med 不評分，也不排名。
譚永輝醫生是做什麼的？
譚永輝醫生是感染及傳染病科醫生。
研究及論文
共 69 篇，顯示最近 12 篇
按論文主題篩選
主題由同一批 PubMed 論文的醫學分類整理，不代表醫生提供相關診治服務。
- Safety and Efficacy of Concomitant Nirmatrelvir/Ritonavir and Direct Oral Anticoagulant Therapies for COVID-19 Among Patients With Atrial Fibrillation.Journal of the American Heart Association · 2026
- Generative Artificial Intelligence Models in Clinical Infectious Disease Consultations: A Cross-Sectional Analysis Among Specialists and Resident Trainees.Healthcare (Basel, Switzerland) · 2025
- Clinical and molecular epidemiology of Streptococcus pneumoniae infections during and in early recovery phase of COVID-19 pandemic in Hong Kong.Journal of infection and public health · 2025
- Comparative Evaluation and Performance of Large Language Models in Clinical Infection Control Scenarios: A Benchmark Study.Healthcare (Basel, Switzerland) · 2025
- Implication of Admission Eosinophil Count and Prognosis of Coronavirus Disease 2019 (COVID-19) in Elderly Patients With COPD: A Territory-Wide Cohort Study.The clinical respiratory journal · 2025
- Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and molnupiravir versus monotherapy with molnupiravir or nirmatrelvir-ritonavir in hospitalized COVID-19 patients: A target trial emulation study.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2025
- Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir-ritonavir in patients hospitalised with COVID-19: a target trial emulation study.The Lancet. Infectious diseases · 2024
- Comparison of safety and efficacy between Nirmatrelvir-ritonavir and molnupiravir in the treatment of COVID-19 infection in patients with advanced kidney disease: a retrospective observational study.EClinicalMedicine · 2024
- Immunogenicity and Safety of the Three-Dose COVID-19 Vaccine Regimen in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis.Kidney diseases (Basel, Switzerland) · 2024
- The impact of vaccine type and booster dose on the magnitude and breadth of SARS-CoV-2-specific systemic and mucosal antibodies among COVID-19 vaccine recipients.Heliyon · 2024
- The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study.EBioMedicine · 2024
- Immune correlates with disease severity in older patients after SARS-CoV-2 BA.2 infection in Hong Kong.Clinical immunology (Orlando, Fla.) · 2024
論文資料來自 PubMed／Europe PMC，按姓名及機構自動配對；每項均可按連結核對。
僅供參考，不構成醫療建議。 閱讀完整免責聲明